准白血病干细胞生物力学抑制干细胞性并增强NK细胞介导免疫疗法
Mingming Zhu1, Haoxiang Yang2, Kailong Qiu2
1Department of Hematology, The First Affiliated Hospital of USTC, National Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Nature communications
|December 1, 2025
概括
急性髓性白血病 (AML) 中的白血病干细胞 (LSC) 在机械上是软的,使得有针对性的隔离. 抑制ALDH1A1会增加LSC的刚性,提高免疫疗法的有效性,并减少白血病的进展.
科学领域:
- 生物医学工程 生物医学工程
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 急性髓性白血病 (AML) 是由白血病干细胞 (LSC) 驱动的,这些干细胞导致复发和对治疗的抵抗.
- 虽然LSC的机械性质在很大程度上还未被探索,但对于理解它们的行为和开发新疗法至关重要.
研究的目的:
- 研究LSCs的机械特性及其在AML中的作用.
- 探索针对LSC机械特征和增强免疫治疗的新型治疗策略.
主要方法:
- 利用微流体芯片,根据机械特性选择性地隔离LSC.
- 在初级人类AML骨髓上进行单细胞RNA测序,以确定LSC亚群.
- 研究了ALDH1A1抑制对LSC度,干度和易受自然杀手 (NK) 细胞细胞毒性的影响.
- 评估了ALDH1A1抑制和NK细胞治疗在AML患者衍生的异种移植模型中的组合.
主要成果:
- 发现LSCs主要是小的和机械软的,允许它们使用微流体芯片进行隔离.
- 确定了FSC低 ALDH1A1+亚种群,该亚种群富含具有长期干系的LSC.
- 抑制ALDH1A1增加了LSC的刚性和减少了干度,增强了NK细胞介导的细胞毒性.
- 结合ALDH1A1抑制与NK细胞治疗,在异种移植模型中显著抑制了白血病的进展.
结论:
- 针对LSC的机械性质是克服AML治疗耐药性的有希望的策略.
- 抑制ALDH1A1可以调节LSC机制,使它们更容易受到免疫治疗的影响.
- 将向疗法与免疫疗法相结合,为改善AML的临床结果提供了一个潜在的方法.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
Stem Cell Therapy for Tissue Regeneration
4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K


